Medifast (MED) Current Leases (2013 - 2026)

Medifast (MED) has 12 years of Current Leases data on file, last reported at $3.9 million in Q1 2026.

• For the quarter ending Q1 2026, Current Leases fell 36.32% year-over-year to $3.9 million; the trailing twelve-month figure through Mar 2026 stood at $3.9 million (down 36.32% YoY), and the FY2025 full-year result was $4.6 million, down 25.54% from the prior year.
• Current Leases for Q1 2026 stood at $3.9 million, down from $4.6 million in the prior quarter.
• Across five years, Current Leases topped out at $6.7 million in Q1 2022 and bottomed at $3.9 million in Q1 2026.
• The 5-year median for Current Leases is $5.9 million (2025), against an average of $5.7 million.
• The widest annual swing landed in 2022, when Current Leases soared 82.5%; it then sank 36.32% in 2026.
• A 5-year view of Current Leases shows it stood at $5.8 million in 2022, then gained by 1.89% to $5.9 million in 2023, then advanced by 5.05% to $6.2 million in 2024, then fell by 25.54% to $4.6 million in 2025, then slipped by 14.84% to $3.9 million in 2026.
• The last three Current Leases figures came in at $3.9 million (Q1 2026), $4.6 million (Q4 2025), and $5.5 million (Q3 2025), per Business Quant data.

Peer Comparison